These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32212672)
1. Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists. Marcher-Rørsted E; Halberstadt AL; Klein AK; Chatha M; Jademyr S; Jensen AA; Kristensen JL ACS Chem Neurosci; 2020 May; 11(9):1238-1244. PubMed ID: 32212672 [TBL] [Abstract][Full Text] [Related]
2. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs. Halberstadt AL; Chatha M; Stratford A; Grill M; Brandt SD Neuropharmacology; 2019 Jan; 144():368-376. PubMed ID: 30385253 [TBL] [Abstract][Full Text] [Related]
4. Effects of the 5-HT Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648 [TBL] [Abstract][Full Text] [Related]
5. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Halberstadt AL; Geyer MA Neuropharmacology; 2014 Feb; 77():200-7. PubMed ID: 24012658 [TBL] [Abstract][Full Text] [Related]
6. The selective 5-HT Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690 [TBL] [Abstract][Full Text] [Related]
7. Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice. Smith DA; Bailey JM; Williams D; Fantegrossi WE J Pharmacol Exp Ther; 2014 Dec; 351(3):485-91. PubMed ID: 25271256 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens. Halberstadt AL Curr Top Behav Neurosci; 2017; 32():283-311. PubMed ID: 28097528 [TBL] [Abstract][Full Text] [Related]
17. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function. Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203 [TBL] [Abstract][Full Text] [Related]
18. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist. Benneyworth MA; Smith RL; Sanders-Bush E Neuropsychopharmacology; 2008 Aug; 33(9):2206-16. PubMed ID: 17957214 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. Hansen M; Phonekeo K; Paine JS; Leth-Petersen S; Begtrup M; Bräuner-Osborne H; Kristensen JL ACS Chem Neurosci; 2014 Mar; 5(3):243-9. PubMed ID: 24397362 [TBL] [Abstract][Full Text] [Related]
20. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice. Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]